Advanced Enzyme Technologies Reports 2% Y-o-Y Revenue Growth in FY25

Advanced Enzyme Technologies Limited, a leading specialty biotech company, announced its unaudited financial results for the fourth quarter and year ended March 2025. The company reported a 2% increase in revenue from operations, standing at ¥ 6,369 million in FY25 compared to ¥ 6,239 million in FY24. However, the consolidated EBITDA declined by 5% to ¥ 1,944 million in FY25 from ¥ 2,045 million in FY24. Profit after tax stood at ¥ 1,340 million during FY25, a 2% decline from ¥ 1,370 million in FY24. The human nutrition segment underperformed by 3%, while the animal nutrition segment outperformed by 12%. The bio-processing segment grew by 6%, and the specialized manufacturing segment contributed 8% to the revenue stream, growing by 30%.